Implementing a Mobile Technology-Based System for Physician-Directed Remote Management of Hypertension: A Pilot Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 31
- 试验地点
- 2
- 主要终点
- Participant Survey
研究概览
简要总结
The primary objective of this study is to assess the feasibility and effectiveness of a mobile-technology based system that integrates patient-facing and clinician-facing components to assist the management of hypertension.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •18 years or older with an established diagnosis of essential hypertension
排除标准
- •Patients on more than 2 antihypertensives at time of enrollment
- •Clinical diagnosis of secondary hypertension, that is, hypertension due to a secondary cause, including but not limited to the following:
- •Renal artery stenosis
- •Primary hyperaldosteronism
- •Cushing syndrome
- •Coarctation of the aorta
- •Drug-induced hypertension
- •Pheochromocytoma
- •Obstructive sleep apnea
- •Hospitalization for malignant hypertension or severe hypertension (including stroke, cardiac events, acute kidney injury) in the preceding 6 months
- •Hospitalization for unstable angina or myocardial infarction in the preceding 6 months
- •Prior diagnosis of heart failure or cardiomyopathy
- •Stroke or transient ischemic attack within prior 6 months
- •Prior organ transplantation
- •Failure to obtain informed consent
- •Pregnant or currently trying to become pregnant
- •Patients who are enrolled in other research studies
结局指标
主要结局
Participant Survey
时间窗: 12 weeks
A survey regarding usability and feedback about the intervention completed by participants. Questions 1 through 5 were rated on a scale of 1 (strongly disagree) to 7 (strongly agree); question 6 was rated on a scale of 1 (extremely confident) to 5 (extremely doubtful).
Physician Survey
时间窗: 12 weeks
A survey regarding usability and feedback about the intervention completed by physicians. Physicians provided survey responses, but were not enrolled in the study. Questions 1, 2, and 3 were rated on a scale of 1 (strongly agree) to 7 (strongly disagree); question 4 was rated on a scale of 1 (extremely confident) to 5 (extremely doubtful); question 5 was rated on a scale of 1 (extremely pleased) to 7 (extremely displeased).
Change in Blood Pressure
时间窗: Assessed at baseline and week 12
Change in systolic and diastolic blood pressure (SBP and DBP).
次要结局
未报告次要终点
研究者
Paul Wang
Professor of Medicine
Stanford University